BCL2L1 has been reported as a key regulator in multiple cancer types including cervical cancer and colorectal cancer (Obasi et al., 2018; Yang et al., 2020; Zhang et al., 2015). This evidence concerns the gene BCL2L1 and cervical carcinoma.